Global Cough Syrup Market Report Based on Development, Scope, Share, Trends, Forecast to 2028

Global Cough Syrup Market is expected to grow at a CAGR 4.21% over the forecast period in global market to account for a higher market value of approximately 6,185.11 million by 2027 by the As per the research study conducted by Qualiket Research the Cough Syrup Market is expected to attain substantial growth by the end of the forecast period. The report offers crucial information pertaining to the total valuation which is presently held by this industry.

Get your Customized Research Report @ https://qualiketresearch.com/request-sample/Cough-Syrup-Market/ask-for-customization

Commonly available Over- The- Counter (OTC) cough & cold medications contain either single or in combination of a decongestant, antihistamine, cough suppressant, expectorant, and antipyretic. High prevalence of cough is expected to be a major driving factor for increasing demand for cough syrup which drives the global cough syrup market growth over the forecast period. For instance, according to the data published by the National Center for Biotechnology Information in 2014, the annual prevalence of cough in the general population is reported as around 10–33 percent across the globe. Furthermore, the increase in pollution is a major challenge for most governments at this point and it is particularly so because as pollution level rise incidence of respiratory illness also increases will positively influence the market growth.

A dry cough can be a sign of something minor like allergies/cold, but it is also a major symptom of COVID-19. According to the scientist dextromethorphan has a “pro-viral” effect that is used for the treatment of dry cough. This pro-viral effect of the drugs helps the coronavirus to replicate and hijack the cells, which may make COVID-19 positive patients feel sicker. Therefore, researchers suggested to avoid cold & flu medicines, especially dextromethorphan, during the COVID-19 pandemic.

Request a Sample Copy of the Research Report @ https://qualiketresearch.com/request-sample/Cough-Syrup-Market/request-sample

Key Players

The report provides some of the key players operating in the global cough syrup market including, Pfizer, Inc., Abbott, Lincoln Pharmaceuticals, Novartis AG, Acella Pharmaceuticals, LLC, GlaxoSmithKline PLC, Procter and Gamble, Sanofi, Reckitt Benckiser Group PLC, Johnson & Johnson Services, Inc., etc.

Regional Analysis

The Global Cough Syrup Market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

APAC accounted for the largest share of revenue in 2019, and is expected to maintain its dominance from 2020 to 2027, owing to the easier availability of cough syrups at retail pharmacies, the increase in geriatric population & less stricter laws regarding the abuse of cough and cold medicines in the region. However, MEA is anticipated to register the fastest growth during the forecast period as governments are investing in the development of healthcare infrastructure and the increase in cases of respiratory disorder.

Market Segmentation

By Product Type

• Expectorants
• Cough Suppressants/Antitussives
• Combination Medications

By Age Group

• Pediatric
• Adults

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Inquire To Know More About This Report @ https://qualiketresearch.com/request-sample/Cough-Syrup-Market/inquire-before-buying

Vishal Thakur
Research Support Specialist
QualiKet Research
6060 N Central Expy #500, TX 75204, U.S.A
Email: sales@qualiketresearch.com
Website: https://qualiketresearch.com

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

This release was published on openPR.